The high S1PR1 and SMAD7 levels reported in inflammatory lesions in MS and other autoimmune diseases and our finding that those levels were suppressed in peripheral blood, points to enrichment of highly expressed SMAD7 cells at inflammation sites and, in parallel, enrichment of poorly expressed SMAD7 CD4+ T cells in peripheral blood. The gene discussed is CD4; the disease is myeloid sarcoma.